US · Healthcare · Health Information Services
EPS came in at -0.16 against a street estimate of -0.17 — a beat of 5.9%.
with an average price target of $36.62.
| Fund | Stake |
|---|---|
| Wellington Management Company LLP | 13.89% |
| Bain Capital Life Sciences Investors, LLC | 12.12% |
| FMR Inc | 6.26% |
| BAMCO Inc | 4.44% |
| HHG PLC | 2.53% |
| Vanguard Portfolio Management, LLC | 2.37% |
| Amvescap Plc. | 2.22% |
| Vanguard Capital Management, LLC | 2.20% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 2026 | 2026-06-18 |
| Quarterly report · Q1 2026 | 2026-05-14 |
| Results announced · Q2 2026 | 2026-05-14 |
| Proxy statement · Q2 2026 | 2026-04-29 |
| Annual report FY2025 | 2026-03-18 |
| Results announced · Q1 2026 | 2026-03-18 |
| Reg FD disclosure · Q1 2026 | 2026-01-12 |
| Quarterly report · Q3 2025 | 2025-11-12 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Heartflow, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-08-05.